Cargando…
Anti-retroviral drugs: current state and development in the next decade
The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV drugs remain in phase III clinical trials. This review summarizes current information on ARV drugs in...
Autor principal: | Zhang, Xingquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925449/ https://www.ncbi.nlm.nih.gov/pubmed/29719774 http://dx.doi.org/10.1016/j.apsb.2018.01.012 |
Ejemplares similares
-
Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development
por: Masuda, Takao
Publicado: (2011) -
Adherence to anti-retroviral drugs
por: Roy, Manas Pratim
Publicado: (2016) -
An autoimmune disease prevented by anti-retroviral drugs
por: Beck-Engeser, Gabriele B, et al.
Publicado: (2011) -
Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa
por: Todd, Jim, et al.
Publicado: (2014) -
State of the art in cardiothoracic surgery: now and the next decade
por: Delmo Walter, E M, et al.
Publicado: (2012)